13F Insight
DOSSIER · 13F-HR · Q3 2025

TYBOURNE CAPITAL MANAGEMENT (HK) LTD

$31M in tracked AUM across 4 positions as of Q3 2025.

TC
CIK 0001553936 · last filed Sep 30, 2025
Total AUM
$31M
as of Q3 2025
Holdings
4
—
positions
Whale Score
53
53
tracked
Activity
—
no data
changes this Q
AI Analysis · Q3 2025

TYBOURNE CAPITAL MANAGEMENT (HK) LTD filed its latest 13F-HR for Q3 2025. See the latest holdings and position changes below.

Quarter at a glance — Q3 2025

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q3 2025.

#HoldingValueSharesWeight
01
TSHA
TAYSHA GENE THERAPIES INC (TSHA US)
$12M3.7M39.1%02
FBRX
FORTE BIOSCIENCES INC (FBRX US)
$12M787K38.1%03
ALMS
ALUMIS INC (ALMS US)
$6M1.4M18.0%04
ZNTL
ZENTALIS PHARMACEUTICALS INC (ZNTL US)
$1M961K4.7%

Filing history

2025Q3Sep 30
$31M▼ 10.4%
4 positionsView →2025Q2Jun 30
$35M▲ 46.6%
6 positionsLocked2025Q1Mar 31
$24M▼ 94.1%
5 positionsLocked2024Q4Dec 31
$398M▲ 11.7%
37 positionsLocked2024Q3Sep 30
$357M▼ 27.5%
34 positionsLocked2024Q2Jun 30
$492M▼ 15.9%
40 positionsLocked2024Q1Mar 31
$585M▼ 12.8%
41 positionsLocked2023Q4Dec 31
$671M▼ 6.2%
39 positionsLocked2023Q3Sep 30
$716M▼ 22.7%
41 positionsLocked2023Q2Jun 30
$925M▼ 6.8%
49 positionsLocked2023Q1Mar 31
$993M▼ 1.0%
49 positionsLocked2022Q4Dec 31
$1.0B▼ 3.6%
27 positionsLocked
Showing 12 of 49